Human Interferon Beta Bioassay Services
Product number: 91400-1 PBL's bioassays for interferons are cytopathic effect inhibition assays, also known as CPE and antiviral assays. Sample types include; tissue culture supernatents; serum from PK studies and delivery formulations. In these assays, one unit is defined as the quantity of interferon required per milliliter to reduce the cytopathic effect of viral infection by 50%. All standards used in our bioassays have…
The supplier does not provide quotations for this product through SelectScience. You can search for similar products in our Product Directory.
Product number: 91400-1
PBL's bioassays for interferons are cytopathic effect inhibition assays, also known as CPE and antiviral assays. Sample types include; tissue culture supernatents; serum from PK studies and delivery formulations. In these assays, one unit is defined as the quantity of interferon required per milliliter to reduce the cytopathic effect of viral infection by 50%. All standards used in our bioassays have been calibrated to the International Reference Standards such as those outlined by the National Institutes of Health [Pestka, S. (1986) Methods of Enzymology, 119, 14-23] and the World Health Organization. Results are normally provided 2-3 weeks after receipt of samples, although assay times may vary.
The bioactivity of human interferon beta is measured using human lung epithelial cells (A549) challenged with encephalomyocarditis virus (EMCV). Assay Sensitivity: 2-5 u/ml. Standard for Human IFN beta (NIH reference: Gxb02-901-535).
